Explore Our Library of Biomanufacturing Resources & Technical Data

Application Notes

Cellastim S – Reconstitution Application Note

Enhanced Cryopreservation of T Cells Using Optibumin®, Recombinant Human Serum Albumin (rHSA)

Retain and Protect Final Cell Product with Optibumin®, a Recombinant Human Serum Albumin (rHSA)

Blog

Controlling Impurities in Cell Culture Media

Explore the Latest Developments in T-reg Research and Clinical Application

Exploring the Latest Research and Opportunities in T-reg Therapy

How Regulatory Bodies Are Driving the Shift to Animal-Origin-Free Solutions in Cell Therapy and Vaccine Development

Optibumin vs Traditional Albumin: Comparing Performance in Cell Wash Applications

Recombinant Albumin for Stabilization of Live-Attenuated Viral Vaccines

Recombinant Virus Platforms are Out in Front in the Race to Develop Vaccines Against SARS-CoV-2 and COVID-19 Disease

SARS-CoV2 and Influenza – Double Threat

Why Do Some Biologics Cross the Finish Line—While Others Crash and Burn?

Data Sheets

Cellastim S – Data Sheet

Exbumin – Data Sheet

Lacromin – Data Sheet

LIF Leukemia Inhibitory Factor – Data Sheet

Lysobac – Data Sheet

Optibumin 20 – Data Sheet

Optibumin 25 – Data Sheet

Optiferrin – Data Sheet

Journal Articles (DOI Links)

Utilization of Recombinant Albumins in the Expansion of Human T Lymphocytes

Product Brochures

InVitria Product Catalog – 2025

Optiferrin – Product Brochure

SDS

Optibumin – Safety Data Sheet

Cellastim S – Safety Data Sheet

Use Guidelines

Cellastim S – Guidelines for Use

Optiferrin – Guidelines for Use

White Papers

Cellastim S – Recombinant Human Serum Albumin in the Generation of Functional Cardiomyocytes from Pluripotent Stem Cells

Optiferrin – Recombinant Transferrin an Iron Transport Protein in Cell Culture Media

Optimizing the Performance of LNP and Liposome Therapeutics with Blood-Free Recombinant Albumin